94768 ⎘
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Nitrogen atoms; Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
Compounds
#2REMODILINS TO PREVENT OR TREAT CANCER METASTASIS, GLAUCOMA, AND HYPOXIA
#3SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS
#4Aminothiazole Compounds as Inhibitors of CTPS1
#55-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY
#6Compounds
#7Sulphonyl urea derivatives as NLRP3 inflammasome modulators
#8CTPS1 INHIBITORS AND USES THEREOF
#9Remodilins for airway remodeling and organ fibrosis
#10REMODILINS TO PREVENT OR TREAT CANCER METASTASIS, GLAUCOMA, AND HYPOXIA
#11Compounds
#12Benzenesulfonamide compouds and their use as therapeutic agents
#13Aminothiazole compounds as inhibitors of CTPS1
#14Sulphonyl urea derivatives as NLRP3 inflammasome modulators
#154-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
#16Benzenesulfonamide compounds and their use as therapeutic agents
#17Benzenesulfonamide compounds and their use as therapeutic agents
#18Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
#19THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
#20COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#21Acyl sulfonamide NaV1.7 inhibitors
#22Heterocyclic inhibitors of the sodium channel
#23Benzenesulfonamide compounds and their use as therapeutic agents
#244-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
#25HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS
#26COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#27Benzenesulfonamide compounds and their use as therapeutic agents
#28Sulfonamides as GPR40- and GPR120-agonists
#29N1-phenylpropane-1,2-diamine compounds with selective activity in voltage-gated sodium channels
#30Sulfonamide compounds and uses as TNAP inhibitors
#314-oxo-4,5-dihydrothiazole derivative, preparation method and use thereof
#32Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
#33Substituted benzenesulfonamides as sodium channel blockers
#34COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND RELATED DISORDERS
#35Method for removing dimethoxybenzyl group
#36NOVEL ANTIVIRAL AGENTS AGAINST HBV INFECTION
#37BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
#38Therapeutic compounds and methods of use thereof
#39Benzenesulfonamide compounds and their use as therapeutic agents
#40Compositions and methods for treating ocular diseases
#41Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels
#42HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL
#43Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels
#444-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
#45Sulfonamide compounds and uses as TNAP inhibitors
#46Cathepsin cysteine protease inhibitors
#47SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN AND DIABETES
#48Sodium channel modulators for the treatment of pain and diabetes
#49Sodium channel modulators for the treatment of pain
#50Antiviral agents against HBV infection
#51Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease
#52Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ]
#53Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#54COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#55Sulfonamide compounds and uses as TNAP inhibitors
#56Sodium Channel Inhibitors
#57CHEMICAL COMPOUNDS
#58Benzenesulfonamide compounds and their use as therapeutic agents
#59Compositions and methods for the treatment of metabolic and related disorders
#60Process for the Production of 2-Amino-5-Fluorothiazole
#61Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#62Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels
#63Bicyclic aryl and heteroaryl sodium channel inhibitors
#64Inhibitors of ion channels
#65Bicyclic derivatives as modulators of voltage gated ion channels
#66Compositions useful as inhibitors of voltage-gated sodium channels
#67Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#68Small molecule inhibitors of kynurenine-3-monooxygenase
#69ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS
#70COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS
#71Proteasome inhibitors for selectively inducing apoptosis in cancer cells
#72DITHIAZOLIDINE AND THIAZOLIDINE DERIVATIVES AS ANTICANCER AGENTS
#73Novel Compounds
#74Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#75Bicyclic derivatives as modulators of voltage gated ION channels
#76Sodium channel inhibitors
#77Benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
#78Inhibitors of ion channels
#79INHIBITORS OF 11-BETA-HYDROXY STERIOD DEHYDROGENASE TYPE 1
#80Compositions useful as inhibitors of voltage-gated sodium channels
#81Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
#82Indane derivatives as modulators of ion channels
#83Trisubstituted thiazole compounds, preparations methods, pharmaceutical compositions and medicals uses thereof
#84Heterocyclic sulfonamides as inhibitors of ion channels
#85Aryl carbonyl derivatives as therapeutic agents
#86Aryl carbonyl derivatives as therapeutic agents
#87Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#88Small molecule inhibitors of kynurenine-3-monooxygenase
#89Bicyclic derivatives as modulators of voltage gated ion channels
#90Inhibitors of ion channels
#91Indane derivatives as modulators of ion channels
#92Thiazolimine compound and oxazolimine compound
#93Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
#94Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
#95Compounds
#96Aryl carbonyl derivatives as therapeutic agents
#97Aryl aniline β2 adrenergic receptor agonists
#98Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
#99Compositions useful as inhibitors of voltage-gated sodium channels
#100Substituted heteroaryl derivatives, compositions, and methods of use
#101Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
#102Serine protease inhibitors
#103Compositions useful as inhibitors of voltage-gated sodium channels
#104Sulfonamide anions as catalysts for NCO oligomerization
#105Benzenesulfonamide compounds and their use as therapeutic agents